Availability of Transgene's 2024 Universal Registration Document (URD)

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer,announces that the French version of its2024 Universal Registration Documentwas filed with theFrench Financial Markets Authority( Autorité des marchés financiers– AMF) on April 10, 2025, under number D.25-0243.This document, available on the AMF's website ( www.amf-france.org ), can be viewed and downloaded (in PDF format in French and English, and...

Illkirch Graffenstaden, 10/04/2025 (informazione.news - comunicati stampa - economia)

announces that the French version of its was filed with the ( – AMF) on April 10, 2025, under number D.25-0243.

This document, available on the AMF's website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene's website (www.transgene.fr)

It includes the following documents:

The Universal Registration Document also includes information on the Company's Environmental, Social and Governance (ESG) factors.

Attachment